It was reported that a 28mm amplatzer amulet left atrial appendage occluders was selected for implant on (b)(6) 2023 using a 14f amplatzer torqvue 45x45 delivery sheath.The device was successfully implanted.Post implant, the patient was on dual anti-platelet therapy (dapt).On 23 october 2023, a 45-day post-implant computed tomography (ct) scan was performed, and a pericardial effusion was noted.On (b)(6) 2023, the patient presented to the emergency department with chest pain.The pericardial effusion was noted to be mild to moderate and circumferential, measured at 1cm.Serial echocardiograms were performed on (b)(6) 2023.No pericardiocentesis was required.The patient was continued on dapt.It was believed that the pericardial effusion was due to the implanted amulet occluder.The patient status was stable.
|
An event of pericardial effusion and cardiac tamponade was reported.A returned device assessment could not be performed as the device remains implanted and was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.Based on the information and imaging received, the cause of the reported incident could not be conclusively determined but is potentially consistent with stabilizing wire perforation of the laa wall.
|